3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with warfarin in 1 studies
| Studies (3-(2,4-dimethoxybenzylidene)anabaseine) | Trials (3-(2,4-dimethoxybenzylidene)anabaseine) | Recent Studies (post-2010) (3-(2,4-dimethoxybenzylidene)anabaseine) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 166 | 8 | 81 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | 3-(2,4-dimethoxybenzylidene)anabaseine (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, W; Hu, Y; Li, J; Liu, R; Pan, X; Peng, J; Yue, Y; Zhang, P | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and warfarin
| Article | Year |
|---|---|
GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-κB signaling pathway through the α7 nicotinic acetylcholine receptor.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Bungarotoxins; Coumarins; Cytokines; Inflammation; Lipopolysaccharides; Mice; NF-kappa B; Nicotinic Antagonists; Oncogene Protein v-akt; Pyridines; RAW 264.7 Cells; Signal Transduction | 2015 |